Lutetium [177Lu] oxodotreotide/dotatate clinical trials

Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs

This study is looking at a treatment called Lutathera for teenagers aged 12 to 17 with specific types of cancer (GEP-NETs and PPGLs). It aims to see how safe it is and how much medicine goes to the right places in the body.